Sturm, E; Roula, D; Luschnig, P; Red, I; Heinemann, A
Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.2905
[Poster]
Web of Science
FullText
FullText_MUG
Roula, D; Theiler, A; Luschnig, P; Sturm, G; Tomazic, P; Marsche, G; Heinemann, A; Sturm, E
Apolipoprotein A-IV exhibits anti-inflammatory properties in vitro and is decreased in allergic patients.
Inflammation: from initiation to restoration; APR 24-26, 2019; Edinburgh, UNITED KINGDOM. 2019.
[Poster]
FullText
Sturm, E; Roula, D; Theiler, A; Luschnig, P; Sturm, GJ; Tomazic, PV; Marsche, G; Heinemann, A
Apolipoprotein A-IV is reduced in serum of allergic patients and acts as an endogenous anti-inflammatory protein
EUR RESPIR J. 2019; 54: -European-Respiratory-Society (ERS) International Congress; SEP 28-OCT 02, 2019; Madrid, SPAIN.
Doi: 10.1183/13993003.congress-2019.OA1625
[Oral Communication]
Web of Science
FullText
FullText_MUG
Roula, D; Theiler, A; Luschnig, P; Sturm, G; Tomazic, P; Marsche, G; Heinemann, A; Sturm, E
Apolipoprotein A-IV potently suppresses eosinophil responsiveness in vitro and alleviates house dust mite-induced airway hyperreactivity in mice
Doctoral Day of the Medical University of Graz; NOV 28, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
FullText
Roula, D; Theiler, A; Luschnig, P; Sturm, GJ, Marsche, G, Heinemann, A; Sturm, EM
Apolipoprotein A-IV potently suppresses eosinophil responsiveness in vitro and alleviates house dust mite-induced airway hyperreactivity in mice
Intrinsic Activity, 2018; 6 (Suppl. 1) . 2018; -24th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEPT 27 – 28, 2018 ; Graz, AUSTRIA.
[Oral Communication]
FullText
Frei-Winterleitner, RB; Luschnig, P; Parzmair, GP; Peinhaupt, M; Schranz, S; Fauland, A; Wheelock, CE; Heinemann, A; Sturm, EM
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice
ALLERGY. 2016; 71: 36-36.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
Frei, R; Luschnig, P; Parzmair, GP; Peinhaupt M; Schranz S; Heinemann A; Sturm EM
Cannabinoid receptor 2 augments human and murine eosinophil responsiveness and deteriorates allergy induced AHR in mice
Symposium on INFLAMMATION & IMMUNOLOGY (Inflame); SEP 13-15, 2015; Graz, Austria. 2015.
[Poster]
Frei, R; Luschnig, P; Parzmair, GP; Peinhaupt M; Schranz S; Heinemann A; Sturm EM
CANNABINOID RECEPTOR 2 AUGMENTS HUMAN EOSINOPHIL RESPONSIVENESS VIA GGαq/MEK/ROCK SIGNALING
Doctoral Day 2015; DEC 11, 2015; Graz, Austria. 2015.
[Oral Communication]
Frei, R; Luschnig, P; Parzmair, GP; Peinhaupt M; Schranz S; Heinemann A; Sturm EM
CANNABINOID RECEPTOR 2 AUGMENTS HUMAN EOSINOPHIL RESPONSIVENESS VIA G Gaq/MEK/ROCK SIGNALING
9th Biennial Symposium of the International Eosinophil Society; JUL 14-18, 2015; Chicago, USA. 2015.
[Poster]
Jandl, K; Bálint, Z; Peinhaupt, M; Luschnig, P; Sturm, E; Konya, V; Olschewski, A; Schuligoi, R; Heinemann, A
Activated PGD2 receptors on macrophages enhance neutrophil recruitment into the lungs
Doctoral Day, 2014; December 10, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Jandl, K; Bálint, Z; Peinhaupt, M; Luschnig, P; Sturm, E; Konya, V; Olschewski, A; Schuligoi, R; Heinemann, A
Activated PGD2 receptors on macrophages enhance neutrophil recruitment into the lungs
Prostaglandins and Other Lipid Mediators. 2014; -Fifth European Workshop on Lipid Mediators; October 23-24, 2014 ; Istanbul, TURKEY.
[Poster]
Maric, J; Konya, V; Jandl, K; Luschnig, P; Lanz, I; Platzer, W; Schuligoi, R; Heinemann, A
Prostaglandin E2 receptor EP4 prevents acute lung injury via enhancing pulmonary microvascular barrier function.
20th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 26-27, 2014; Innsbruck, AUSTRIA. 2014.
[Oral Communication]
Heinemann, A; Sturm, E; Luschnig, P; Konya, V; Schuligoi R
Role of prostaglandins in leukocyte traffickig through the endothelium
5th Symposium on Cardiovascular Medicine; JAN 15, 2011; Taichung, TAIWAN. 2011.
[Keynote lecture]
Heinemann, A; Luschnig, P; Sturm, E; Schuligoi, R
Development and pharmacology of CRTH2 antagonists
AstraZeneca Pharmacology Forum; OCT 13, 2010; Vienna, AUSTRIA. 2010.
[Keynote lecture]
Konya, V; Sturm, EM; Luschnig, P; Üllen, A; Sattler, W; Heinemann, A
ProstaglandinE2 is barrier protective on pumonary endothelial cells via activating EP4 receptor.
Conference book of the GRC meeting2010; -Gordon Research Conference on Endothelial Cell Phenotype in Health and Disease; August 8-13, 2010 ; Biddeford, Maine, USA.
[Poster]
Sturm, E; Parzmair, GP; Luschnig-Schratl, P; Konya, V; Heinemann, A
EP4 PROSTANOID RECEPTOR SIGNALING IN HUMAN EOSINOPHILS
CYTOMETRY PART B-CLIN CYTOM. 2010; 78B(6): 421-422.
[Poster]
Web of Science
Sturm, EM; Parzmair, GP; Luschnig-Schratl, P; Konya, V; Heinemann, A;
EP4 Prostanoid Signaling in Human Eosinophils.
Final Program of the 10th Euroconference on Clinical Cell Analysis2010; 101--SIC and ESCCA 2010; SEPT 22-25, 2010; Valencia, SPAIN.
[Poster]
Luschnig-Schratl, P; Sturm, EM; Kónya, V; Schuligoi, R; Heinemann, A
Inhibitory effects of prostaglandin EP4 receptors on human eosinophils.
15th Scientific Symposium of the Austrian Pharmacological Society (APHAR)2009; Volume 9(A2):-15th Scientific Symposium of the Austrian Pharmacological Society (APHAR); NOV 19-21, 2009; Graz, AUSTRIA.
[Poster]
Sturm, EM; Parzmair, GP; Luschnig, P; Konya, V; Heinemann, A
KINASES INVOLVED THE INHIBITION OF EOSINOPHIL MIGRATION.
BMC Pharmacology2009; 9(A34):15--15th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
; NOV 19-21, 2009; Graz, AUSTRIA.
[Poster]
FullText
Schratl, P; Royer, JF; Kostenis, E; Sturm, EM; Schuligoi, R; Lippe, IT; Peskar, BA; Heinemann, A
Role of the prostaglandin D 2 receptors, CRTH2 and DP, in eosinophil chemotaxis and mobilization from bone marrow
PHARMACOLOGY. 2006; 78(3):149-149.
[Oral Communication]
Web of Science